Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic healthcare solutions serving to enhance the health and well being of people around the globe with well known and respected products that provide healthcare professionals with accurate and cost-effective diagnostic information at the point of care (POC).

Core competencies and capabilities include:

• Immunoassay development and automated manufacturing
• Lateral Flow (LF): infectious disease, women's health
• Direct Fluorescent Antibodies (DFA) : infectious disease, virology
• Microtiter: bone and complement pathway markers
• Monoclonal antibody characterization and development
• Molecular assay development

Link to Quidel (IVD)